Leaflet IVACAFTOR STADA 150mg film-coated tablets
Ivacaftor is a medication used for the treatment of cystic fibrosis in patients with specific CFTR gene mutations. It works by improving the function of the CFTR protein, facilitating chloride transport across cell membranes.
The medication is taken orally, usually twice daily with fat-containing food, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include headache, abdominal pain, diarrhea, or skin rashes. In rare cases, severe hepatic reactions or elevated liver enzymes may occur.
Ivacaftor is not recommended for patients with hypersensitivity to this medication or severe hepatic impairment.
The medication is taken orally, usually twice daily with fat-containing food, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include headache, abdominal pain, diarrhea, or skin rashes. In rare cases, severe hepatic reactions or elevated liver enzymes may occur.
Ivacaftor is not recommended for patients with hypersensitivity to this medication or severe hepatic impairment.
General data about IVACAFTOR STADA 150mg
- Substance:
- ivacaftor
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W71864001
- Concentration:
- 150mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 56
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for ivacaftor
Concentrations available for ivacaftor
- 150mg
- 25mg
- 50mg
- 59.5mg
- 75mg